Study: Amputation Rate Decreased with HBOT
A study published in 2008 evaluated the efficacy of HBOT with respect to decreasing amputation rates for patients with diabetic foot ulcer. A total of 184 consecutive patients were treated with HBOT (one hour sessions, six days a week with examinations performed at three, six and 12 month intervals) as an adjunct to standard treatment modalities for diabetic foot ulcer. Following treatment, 115 (62 percent) were completely healed, 31 (17 percent) showed no improvement and 38 (21 percent) underwent amputation. HBOT’s success was illustrated by the attenuation to hypoxic tissue by the mechanisms of angiogenesis, fibroblast replication, collagen synthesis, revascularization, epithelialization and increased leukocyte bactericidal activity. This study confirmed that HBOT Can help to reduce major amputation rates in diabetic foot ulcers by repairing tissue. This finding is especially noteworthy considering other conventional treatments had failed.